Jon S. Saxe serves as Executive at PDL BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, Jon S. Saxe has executed 160 insider transactions totaling $3.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 13, 2006 involved selling 5,000 shares valued at $160.2K.
Jon S. Saxe currently holds 5,751 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jon S. Saxe has been a net seller of PDLI stock. They have purchased $205.0K and sold $3.1M worth of shares.
Jon S. Saxe's most recent insider trade was on Mar 13, 2006, when they sold 5,000 shares at $32.04 per share.
Get notified when new Form 4 filings are submitted
| $32.12 |
| Discretionary |
| Mar 6, 2006 | PDLI | $156.8K | Sale | 5,000 | $31.37 | Discretionary |
| Mar 3, 2006 | PDLI | $160.0K | Sale | 5,000 | $32.00 | Discretionary |
| Feb 27, 2006 | PDLI | $153.6K | Sale | 5,000 | $30.71 | Discretionary |
| Feb 24, 2006 | PDLI | $150.0K | Sale | 5,000 | $30.00 | Discretionary |
| Jan 9, 2006 | PDLI | $31.2K | Sale | 1,000 | $31.17 | Discretionary |
| Jan 9, 2006 | PDLI | $152.9K | Sale | 5,000 | $30.59 | Discretionary |
| Jan 5, 2006 | PDLI | $150.0K | Sale | 5,000 | $30.00 | Discretionary |
| Jan 4, 2006 | PDLI | $150.2K | Sale | 5,000 | $30.03 | Discretionary |